Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Levodopa
by Most Patent Filings in the South Korea in 2019

The Levodopa top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filings Levodopa Key Players in the South Korea. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, is an amino acid that is made and used as part of the normal biology of humans, as well as some animals and plants. Humans, as well as a portion of the other animals that utilize l-DOPA in their biology, make it via biosynthesis from the amino acid l-tyrosine. l-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. Furthermore, l-DOPA itself mediates neurotrophic factor release by the brain and CNS. l-DOPA can be manufactured and in its pure form is sold as a psychoactive drug with the INN levodopa; trade names include Sinemet, Pharmacopa, Atamet, Stalevo, Madopar, and Prolopa. As a drug, it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia.
#
Company Name
Region
Tech Topics
Total
1
Peptron, Inc.
Peptide,Drug development,Medicine,
...[+2]
Patent: 7
2
KOREA UNITED PHARM, Inc.
Pharmaceutical drug,Medicine,Health care
Patent: 3
3
Asan Foundation
Patent: 2
4
LG Chem Ltd.
Petrochemical,Synthetic rubber,Health care,
...[+2]
Patent: 1
5
CJ CheilJedang Corp.
Sugar,Food processing,Food industry,
...[+2]
Patent: 1
Page generation time: Jun 26 2025